Journal of Personalized Medicine Receives an Updated Impact Factor of 3.0

We are pleased to share that Journal of Personalized Medicine (JPM, ISSN: 2075-4426) was awarded an updated Impact Factor of 3.0 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024. Journal of Personalized Medicine ranks Q1 (58 among 325 titles) in the “Medicine, General &  Internal” category and Q2 (51 among 174 titles) in the “Health Care Sciences & Services” category.

For further statistics, please visit https://www.mdpi.com/journal/jpm/stats. For more information about MDPI flagship journals' citation metrics, please see here.

At MDPI, our mission is simple yet powerful, and we strive every day to make scientific research freely accessible to everyone, everywhere. With over 3.5 million authors choosing MDPI, we have established ourselves as a key player driving the open access initiative.

Our journals have received over 12,728 citations in the Web of Science, making us the most cited open access publisher. With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services.

JPM Editorial Office